Literature DB >> 12607131

Differential G protein receptor kinase 2 expression in compensated hypertrophy and heart failure after myocardial infarction in the rat.

J Theilade1, C Strøm, T Christiansen, S Haunsø, S P Sheikh.   

Abstract

The onset of heart failure is associated with characteristic changes in myocardial expression of G protein receptor kinase 2 (GRK2). Although, GRK2 significantly contributes to the regulation of myocardial function in the failing heart, the GRK2 expression during cardiac hypertrophy without heart failure remains to be explored. We here report a differential expression of GRK2 in cardiac hypertrophy with or without heart failure in response to a myocardial infarction in the rat. Postmyocardial infarction animals were divided into two groups depending on the absence or presence of pulmonary edema, which is a manifestation of heart failure. Remarkably, cardiac GRK2 expression and activity were inhibited in animals with cardiac hypertrophy without heart failure, whereas animals with heart failure had elevated GRK2. Thus, three weeks after the infarction cardiac GRK2 expression in animals with hypertrophy alone was decreased to 0.34 of control, whereas in the group of animals with heart failure GRK2 expression was 1.89-fold higher than in sham-operated animals. GRK2 activity was affected in a similar way, three and nine weeks after the infarction cardiac GRK2 activity was reduced to 0.58 and 0.62 in animals with hypertrophy without heart failure when compared to sham operated animals. By contrast, GRK2 activity was increased by 1.32- and 1.21-fold three and nine weeks postinfarction in animals with heart failure when compared to sham animals. These data suggest that GRK2 expression is differentially regulated in hypertrophic, non-failing and hypertrophic, failing hearts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12607131     DOI: 10.1007/s00395-003-0395-x

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  11 in total

1.  The GRK2 Overexpression Is a Primary Hallmark of Mitochondrial Lesions during Early Alzheimer Disease.

Authors:  Mark E Obrenovich; Hector H Palacios; Eldar Gasimov; Jerzy Leszek; Gjumrakch Aliev
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-03-03

Review 2.  The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets.

Authors:  Petronila Penela; Cristina Murga; Catalina Ribas; Vanesa Lafarga; Federico Mayor
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 3.  The evolving impact of g protein-coupled receptor kinases in cardiac health and disease.

Authors:  Priscila Y Sato; J Kurt Chuprun; Mathew Schwartz; Walter J Koch
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

4.  Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions.

Authors:  Mark E Obrenovich; Mark A Smith; Sandra L Siedlak; Shu G Chen; Jack C de la Torre; George Perry; Gjumrakch Aliev
Journal:  Neurotox Res       Date:  2006-08       Impact factor: 3.911

Review 5.  Regulatory SNPs and transcriptional factor binding sites in ADRBK1, AKT3, ATF3, DIO2, TBXA2R and VEGFA.

Authors:  Norman E Buroker
Journal:  Transcription       Date:  2014-10-31

6.  Cardiac progenitor cells engineered with βARKct have enhanced β-adrenergic tolerance.

Authors:  Mohsin Khan; Sadia Mohsin; Haruhiro Toko; Monique Alkatib; Jonathan Nguyen; Silvia Truffa; Natalie Gude; Kurt Chuprun; Douglas G Tilley; Walter J Koch; Mark A Sussman
Journal:  Mol Ther       Date:  2013-09-03       Impact factor: 11.454

7.  Regulation of cardiac fibroblast-mediated maladaptive ventricular remodeling by β-arrestins.

Authors:  Jennifer L Philip; Xianyao Xu; Mei Han; Shahab A Akhter; Md Abdur Razzaque
Journal:  PLoS One       Date:  2019-07-03       Impact factor: 3.240

Review 8.  Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation.

Authors:  Mark E Obrenovich; Ludis A Morales; Celia J Cobb; Justin C Shenk; Gina M Méndez; Kathryn Fischbach; Mark A Smith; Eldar K Qasimov; George Perry; Gjumrakch Aliev
Journal:  J Cell Mol Med       Date:  2008-10-06       Impact factor: 5.310

9.  Myocardial Ablation of G Protein-Coupled Receptor Kinase 2 (GRK2) Decreases Ischemia/Reperfusion Injury through an Anti-Intrinsic Apoptotic Pathway.

Authors:  Qian Fan; Mai Chen; Lin Zuo; Xiying Shang; Maggie Z Huang; Michele Ciccarelli; Philip Raake; Henriette Brinks; Kurt J Chuprun; Gerald W Dorn; Walter J Koch; Erhe Gao
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

Review 10.  G-protein-coupled receptor kinase 2 and endothelial dysfunction: molecular insights and pathophysiological mechanisms.

Authors:  Kumiko Taguchi; Takayuki Matsumoto; Tsuneo Kobayashi
Journal:  J Smooth Muscle Res       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.